QUOTED. April 3, 2019. Scott Gottlieb.
To keep up with advances in artificial intelligence and machine learning in the health-care sector, US FDA is working to develop a draft guidance that would help sponsors gain clarity on what the agency expects from them. See what agency head Scott Gottlieb said about AI here.
“I can envision a world where, one day, artificial intelligence can help detect and treat challenging health problems, for example, by recognizing the signs of disease well in advance of what we can do today. These tools can provide more time for intervention, identifying effective therapies and ultimately saving lives.” –Scott Gottlieb, commissioner, US FDA
Click here for a free trial of Medtech Insight